These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 14612950

  • 1. Similar immune responses and antitumor effects of murine dendritic cells loaded with either exogenous or endogenous-synthesized protein.
    Lacave R, Masurier C, Guigon M, Lemoine FM, Klatzmann D, Colombo BM.
    Int J Oncol; 2003 Dec; 23(6):1747-53. PubMed ID: 14612950
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
    Murakami T, Tokunaga N, Waku T, Gomi S, Kagawa S, Tanaka N, Fujiwara T.
    Clin Cancer Res; 2004 Jun 01; 10(11):3871-80. PubMed ID: 15173096
    [Abstract] [Full Text] [Related]

  • 6. Immortalized dendritic cell line with efficient cross-priming ability established from transgenic mice harboring the temperature-sensitive SV40 large T-antigen gene.
    Ebihara S, Endo S, Ito K, Ito Y, Akiyama K, Obinata M, Takai T.
    J Biochem; 2004 Sep 01; 136(3):321-8. PubMed ID: 15598888
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
    He T, Tang C, Xu S, Moyana T, Xiang J.
    Cell Mol Immunol; 2007 Apr 01; 4(2):105-11. PubMed ID: 17484804
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S, Yuan J, Xiang J.
    J Leukoc Biol; 2007 Oct 01; 82(4):829-38. PubMed ID: 17626150
    [Abstract] [Full Text] [Related]

  • 13. The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells.
    Fujisawa Y, Nabekura T, Nakao T, Nakamura Y, Takahashi T, Kawachi Y, Otsuka F, Onodera M.
    Exp Dermatol; 2009 Apr 01; 18(4):396-403. PubMed ID: 19054057
    [Abstract] [Full Text] [Related]

  • 14. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK, Stephani J, Schaefer M, Kalay H, García-Vallejo JJ, den Haan J, Saeland E, Sparwasser T, van Kooyk Y.
    Mol Immunol; 2009 Dec 01; 47(2-3):164-74. PubMed ID: 19818504
    [Abstract] [Full Text] [Related]

  • 15. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice.
    Saha A, Chatterjee SK, Foon KA, Primus FJ, Sreedharan S, Mohanty K, Bhattacharya-Chatterjee M.
    Cancer Res; 2004 Jul 15; 64(14):4995-5003. PubMed ID: 15256474
    [Abstract] [Full Text] [Related]

  • 16. Intratumoral immunization with tumor RNA-pulsed dendritic cells confers antitumor immunity in a C57BL/6 pancreatic murine tumor model.
    Schmidt T, Ziske C, Märten A, Endres S, Tiemann K, Schmitz V, Gorschlüter M, Schneider C, Sauerbruch T, Schmidt-Wolf IG.
    Cancer Res; 2003 Dec 15; 63(24):8962-7. PubMed ID: 14695214
    [Abstract] [Full Text] [Related]

  • 17. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T, Kamigaki T, Nakamura T, Imanishi T, Hayashi S, Kawasaki K, Takase S, Ajiki T, Kuroda Y.
    Oncol Rep; 2006 Dec 15; 16(6):1317-24. PubMed ID: 17089056
    [Abstract] [Full Text] [Related]

  • 18. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity.
    Stubbs AC, Martin KS, Coeshott C, Skaates SV, Kuritzkes DR, Bellgrau D, Franzusoff A, Duke RC, Wilson CC.
    Nat Med; 2001 May 15; 7(5):625-9. PubMed ID: 11329066
    [Abstract] [Full Text] [Related]

  • 19. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z, Ahmed KA, Hao S, Zhang X, Xie Y, Munegowda MA, Meng Q, Chibbar R, Xiang J.
    Autoimmunity; 2008 Nov 15; 41(7):501-11. PubMed ID: 18855194
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.